Uncontrolled Postviral Asthma and Persistent Symptoms After COVID-19

Patients with long covid referred for physical rehabilitation at the Norwegian Sports Medicine Centre - Football Association in Oslo, Norway, were assessed for postviral asthma.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Long COVID COVID-19 Chronic Disease Coronaviridae Infections Coronavirus Infections Disease Disease Attributes Infections Lung Diseases Nidovirales Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral Post-Acute COVID-19 Syndrome Post-Infectious Disorders RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Idrettens Helsesenter

Oslo, Norway

About this study

All patients performed methacholin bronchial provocation test, and those with a negative bronchial provocation were eqipped with an app-based spirometer to detect excessive lung variability. Eventual detection of postviral asthma will be treated according to GINA guidelines and eventual effect will be assessed by lung function variability and symptoms.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

° Patients with long covid for more than 6 months referred for physical rehabilitation

Exclusion criteria

° None

Treatment and study plan

App-based spirometer

Diagnostic Test

App-based spirometer to perform serial spirometry to assess lung function variatione

Primary outcomes

Excessive lung function variation

Time frame: 8 months

Lung function given as FEV1.
Perceived symptoms of long covid

Time frame: 8 months

On a Likert scale 1-10

Sponsors and collaborators

Lead sponsor

The Norwegian Sports Medicine Centre - Football Association, Oslo, Norway

Other

Registry information

Official study title

Uncontrolled Postviral Asthma in Patients With Long Covid

Acronym: COVID-19

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Jun 26, 2023
Registry last updated: Jun 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed